# Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pembrolizumab-plus-chemotherapy-in-squamous-non-small-cell-lung-cancer-5-year/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Silvia Novello,Dariusz M. Kowalski,Alexander Luft,Mahmut Gümüş,David Vicente,Julien Mazières,Jerónimo Rafael Rodríguez‐Cid,Ali Tafreshi,Ying Cheng,Ki Hyeong Lee,Alexander Golf,Shunichi Sugawara,Andrew Robinson,Balázs Halmos,Erin Jensen,Paul Schwarzenberger,M. Catherine Pietanza,Luis Paz‐Ares |
| Citations | 537 |
| DOI | 10.1200/jco.22.01990 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.22.01990?role=tab |
| OpenAlex ID | https://openalex.org/W4319068412 |
| PMID | 36735893 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Silvia Novello](https://scholariq.org/researchers/silvia-novello/)
- [Julien Mazières](https://scholariq.org/researchers/julien-mazieres/)
- [Ying Cheng](https://scholariq.org/researchers/ying-cheng/)
- [Balázs Halmos](https://scholariq.org/researchers/balazs-halmos/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.